Search Results
Jul 14, 2026, 22:24 ET NATIONAL CIVIL RIGHTS TRIAL ATTORNEY JOHN GOMEZ TO ANNOUNCE WHISTLEBLOWER RETALIATION LAWSUIT AGAINST CORONA-NORCO UNIFIED SCHOOL DISTRICT
The lawsuit was filed on behalf of Alejandrina King, a Registered Behavior Technician (RBT), who alleges she was retaliated against after repeatedly reporting what she believed were violations of a special education student's Individualized
More news about: Gomez Trial Attorneys
Apr 30, 2026, 08:00 ET Renibus Therapeutics Announces Oral Presentation on Phase 3 PROTECT Trial Data for RBT-1 at the American Association for Thoracic Surgery (AATS) Annual Meeting
second late-stage program, RBT-1, recently completed the PROTECT Phase 3 trial evaluating RBT-1 in patients undergoing cardiac surgery. Results from this trial suggest that further development in risk-enriched patients may be warranted and is currently under evaluation. RBT-1 has received Breakthrough
More news about: Renibus Therapeutics
Apr 21, 2026, 11:11 ET /C O R R E C T I O N -- Behavior Frontiers, LLC/
Council of Autism Service Providers - CASP). Her research has focused on RBT training models and apprentice-based pathways for developing high-quality behavior analysts."We are thrilled to welcome Dr. Hartley to the Behavior
More news about: Behavior Frontiers, LLC
Mar 26, 2026, 16:05 ET Renibus Therapeutics Announces Participation at the 25th Annual Needham Virtual Healthcare Conference
for the treatment of metabolic acidosis in adults with chronic kidney disease. The Company's second late-stage program, RBT-1, recently completed the PROTECT Phase 3 trial evaluating RBT-1 in patients undergoing cardiac surgery. Results from this trial suggest that further development in risk-enriched
More news about: Renibus Therapeutics
Mar 13, 2026, 10:30 ET Breath Analyzers Market worth $5.63 billion by 2031 | MarketsandMarkets™
https://www.marketsandmarkets.com/requestsampleNew.asp?id=57484012Law enforcement agencies accounted for the largest market share in 2025.Many countries have introduced random breath testing (RBT) programs as a preventive strategy to deter drunk driving. Under these programs, law enforcement officers can stop drivers at random and test their BAC
More news about: MarketsandMarkets
Feb 23, 2026, 10:00 ET Soar Autism Center Announces Free 40-Hour RBT Training To Support ESDM-Focused Learning
Martin. "By aligning RBT training with ESDM principles, we're helping raise the standard of care for children with autism everywhere."The training is available now through Soar's website, with participants receiving a completion certificate verifying fulfillment of the 40-hour RBT training requirement
More news about: Soar Autism Center
Feb 19, 2026, 16:05 ET Renibus Therapeutics Announces Participation at the 36th Annual Oppenheimer Life Sciences Conference
treatment of metabolic acidosis in adults with chronic kidney disease.The Company's second late-stage program, RBT-1, recently completed the PROTECT Phase 3 trial evaluating RBT-1 in patients undergoing cardiac surgery. Results from this trial suggest that further development in risk-enriched patients
More news about: Renibus Therapeutics
Feb 18, 2026, 07:35 ET Knight Therapeutics anuncia a submissão regulatória de NIKTIMVO® (axatilimabe) no Brasil
10 (2023): 1864-1875. doi:10.1200/JCO.22.00958 Associação Brasileira de Transplante de Órgãos. (2024). Registro Brasileiro de Transplantes (RBT): Dados numéricos da doação de órgãos e transplantes realizados por estado e instituição no período: janeiro/setembro 2024 (Ano XXV, nº 3) [Relatório].
More news about: Knight Therapeutics Inc.
Feb 18, 2026, 07:35 ET Knight Therapeutics anuncia la solicitud de autorización regulatoria de NIKTIMVO® (axatilimab) en Brasil
núm. 10 (2023): 1864-1875. doi:10.1200/JCO.22.00958Associação Brasileira de Transplante de Órgãos. (2024). Registro Brasileño de Trasplantes (RBT): Datos numéricos de la donación de órganos y trasplantes realizados por estado e institución en el período: enero/septiembre 2024 (Año XXV, nº 3) [Informe].
More news about: Knight Therapeutics Inc.